The Comparative Toxicogenomics Database (CTD;
INTRODUCTION
Exposure to environmental chemicals may influence human health (1, 2) . The molecular mechanisms of action between chemicals and gene products, however, are not well understood. Toward that end, the Comparative Toxicogenomics Database (CTD; http://ctdbase.org) is a public resource that provides information about the interaction of environmental chemicals with gene products and their effect on human disease (3) (4) (5) (6) . This information is first garnered from the scientific literature by professional biocurators who manually curate a triad of core interactions including chemical-gene, chemical-disease and gene-disease relationships (7). These core data are then internally integrated to generate inferred chemical-genedisease networks. Additionally, the core data are integrated with external data sets such as Gene Ontology (GO) and pathway annotations (from KEGG and Reactome) to establish novel inferences. A unique and powerful feature of CTD is the inferred relationships generated by data integration, following the Swanson ABC model of knowledge transfer (8) : if chemical A interacts with gene B and independently gene B is directly associated with disease C, then chemical A has an inferred relationship to disease C (inferred via gene B). This knowledge transfer can be expanded to include any type of information directly annotated to chemicals, genes or diseases; thus, if GO term A is annotated to gene B, and independently gene B directly interacts with chemical C, then GO term A has an inferred relationship to chemical C (inferred via gene B). Such inferred connections can be statistically scored to help indicate the significance of the association (B. L. King et al., submitted for publication), provide novel insights that expand CTD content (4) and allow users to analyze toxicogenomic information from different perspectives. These inferences make CTD more informative than the sum of its individual curated parts (7) .
To increase the efficiency and productivity of manual curation, we developed and implemented several procedures, including the use of a streamlined curation paradigm (7); development of a sophisticated, yet easy-to-use, web-based annotation tool for remote biocurators (7) and the creation and adoption of practical controlled vocabularies (9) . Selecting articles for manual curation at CTD is typically performed via a chemical-centric approach, wherein PubMed (http://www.ncbi.nlm.nih .gov/pubmed/) is queried for publications that describe a chemical-of-interest. To complement this process, we recently introduced a new journal-centric approach for triaging literature to help ensure data currency in CTD (A. P. Davis et al., submitted for publication). We also continue to refine text-mining processes to rank and prioritize articles for curation (10, 11) . Finally, a collaborative project with Pfizer, Inc. (see below) provided an additional corpus of over 80 000 toxicology papers.
Here, we provide an update to CTD, describing its increased data content and several new analytical and visualization tools and enhancements since our 2011 report (4) . These updates further expand the utility of CTD for environmental health research.
NEW FEATURES

Increased data content
In September 2010, CTD initiated a collaborative project with Pfizer, Inc. to curate a corpus of >80 000 Pfizerselected toxicology papers triaged for therapeutic drug interactions with four diseases-of-interest (cardiovascular, renal, neurological and hepatic disorders). In 10 months, five CTD biocurators manually reviewed the entire corpus and found that 53 951 of the papers contained curatable data for CTD. Curated data from this project are now fully integrated with core CTD and freely available to all users. The curation of the Pfizer corpus, along with CTD's regular literature selection process, has dramatically increased the database content. In July 2012, CTD  contained data from 94 513 articles, from whence  799 204 interactions were manually curated (599 182  chemical-gene, 176 627 chemical-disease and 23 395 gene-disease interactions) for 11 755 unique chemicals, 27 950 unique genes and 5987 unique diseases (Table 1) . Internal integration of these data generates >10.1 million inferred gene-disease relationships and 913 622 inferred chemical-disease relationships. Integration with external data sets from GO (12) and pathway annotations from KEGG (13) and Reactome (14) provides the basis for additional inferred relationships. In total, 15.6 million toxicogenomic relationships are provided for analysis, representing a 3.6-fold increase in content since our last report in 2011 (4) and a 10.6-fold increase since our original report in 2009 (5) . To make the most of this updated content, new users of CTD should consult our 'Help' menu (http://ctdbase.org/help) and 'FAQ' section (http://ctdbase.org/help/faq/) for more information and step-by-step instructions about performing simple and advanced queries in CTD.
Link-outs and adoption of CTD content by other databases CTD continues to expand its connectivity with external databases. We now include links on CTD Chemical pages to ChEBI (15), a dictionary of molecular entities focused on small chemical compounds; to PubChem (16), a repository of chemical compounds and their associated biological activities; and to TOXLINE (17) , a bibliographic database of toxicology articles. CTD Gene pages now link to WikiGenes, an author-driven wiki system of biological information (18) and NCBI Gene (19) provides links back to CTD Gene pages. In total, CTD links out to 25 external databases from our Chemical, Gene, Disease, Organism, GO, Pathway and Reference pages ( Table 2) . As a federally funded public database, CTD content is often linked to, repackaged or integrated with other database products. Currently, we are aware of 37 external databases that either use CTD content at their site or link back to CTD (Table 3) . This connectivity augments data access for users of both CTD and other linked resources. This interoperability and adoption of CTD data allows for cross-integration of additional information with CTD content in the future. In compliance with the bioDBcore initiative (20) , the core attributes describing CTD are provided in Supplementary  Table S1 . CTD data files are freely available from either individual pages or our 'Downloads' tab (http://ctdbase .org/downloads/) in multiple formats (CSV, TSV, XML, Excel and OBO).
Enhanced data features
We enhanced CTD by adding four new computational and network scoring features: In addition to intuitive disorders such as intellectual disability and schizophrenia (the top two comparable diseases identified), it is also discovered that autism shares many genes with non-obvious diseases (red boxes) such as prostatic neoplasms (30 genes), lung neoplasms (17 genes), hypotension (12 genes), obesity (10 genes) and hypertension (11 genes). Clicking on the hyperlinked gene count in the right-hand column opens another window listing the common interacting genes. The Similarity Index is derived from the Jaccard similarity coefficient (22) .
with similar chemical and gene interaction profiles, including whether the relationship is etiological or therapeutic and ranks them based upon their similarity index to produce a list of comparable disorders. DiseaseComps that are based on genes with a marker/mechanism relationship to autistic disorder include intellectual disability and schizophrenia, as well as less intuitive diseases such as prostate and lung cancer, hypotension, hypertension and obesity (Figure 1 ), provoking the testable hypotheses of whether similar pathways may be involved in these disorders and subsequently if current therapeutics for those diseases might also have beneficial effects on autism. (ii) Filtering data sets. The ability to filter data based upon the type of interactions (as shown above for DiseaseComps) was also applied to other analytical tools in CTD. GeneComps and ChemComps (22) can now be filtered by the type of interaction (activity, expression, binding) and by the direction of the interaction (increase versus decrease) to provide the user with more comparable results.
For example, chemicals that increase the expression of gene HMOX1 also increase the expression of a group of genes (including NQO1, GCLC and NOS2), while chemicals that decrease the expression of HMOX1 decrease the expression of a very different gene set ( Figure 2 statistics to evaluate these inferred gene-disease relationships. These scores allow users to sort and rank the predicted gene-disease relationships to help prioritize hypothesis testing. (iv) Enriched pathway relationships. KEGG and Reactome are resources that provide widely used annotations that assign gene products to molecular pathways (13, 14) . Typically, such pathway annotations are used to retrieve and organize extensive biological knowledge about gene lists. We have uniquely used these genetic pathway annotations to help explore the actions of non-genetic molecules (i.e. chemicals) by associating pathway data with chemicals via their curated interacting genes. These data are provided on the 'Pathway' data tabs for chemicals. They are calculated similar to our previously described enriched GO annotations for chemicals (4) and are intended to help users generate testable hypotheses about molecular pathways perturbed by chemical exposures.
New tools
To help navigate the 15.6 million toxicogenomic relationships in CTD, we created a package of analytical and visualization tools, accessible under the 'Analyze' menu. We have previously described the Batch Query, VennViewer and MyGeneVenn tools (4, 5) . To this suite, we added the following: A user can access the tool directly (http://ctdbase .org/tools/enricher.go) with their specific list of genes (using either NCBI gene symbols or accession identifiers), choose their enrichment analysis and configure the results via any corrected (or raw) P-value threshold. The tool is also integrated with every chemical-disease view in CTD (i.e. the 'Diseases' data tab on a CTD Chemical page or the 'Chemicals' data tab on a CTD Disease page). For example, CTD indicates that the organophosphorus nerve agent Soman interacts with 14 genes known to play a role in seizures, forming the inference network 'Soman-14 genes-seizures' (Figure 3 ). With the Gene Set Enricher tool options embedded in the web display, users simply click on the 'GO' button under the 'Enrichment Analysis' column to identify GO terms that are enriched for those 14 genes. The output ranks 84 GO terms enriched for these 14 genes, including the biological processes synaptic transmission (GO:0007268) and cognition (GO:0050890). From this results page, users can further revise the analysis by selecting corrected versus raw P-values, changing the P-value threshold and filtering the results via the three ontology branches of GO ( Figure 3) . Similarly, by clicking on the 'Pathway' button under the 'Enrichment Analysis' column, users can identify pathways that are enriched for those genes and learn more about the molecular mechanisms that may underlie a chemical-disease connection. For example, the most highly enriched pathway for the Soman-seizures relationships (data not shown) is the neuroactive ligand-receptor interaction (KEGG:04080).
New visualization strategies
A growing challenge for databases is developing ways to visualize large data sets to enhance knowledge management for the user (23) (24) (25) . Toward that end, CTD has begun implementing processes to visualize our content using three different approaches.
(i) All curated chemical-gene interactions are now color-coded on web pages to indicate the directionality of the interaction. Statements that describe an 'increase' in an interaction are colored red, 'decrease' interactions are displayed in green and for instances where the direction is not specified by the authors, the interaction is colored brown (Figure 4a ). The red/ green color choice parallels the directionality described in early microarray assays. (ii) The 'ChemComps' data tab on a CTD Chemical page now provides the option to visualize the networks of common interacting genes for the top 10 ranked comparable chemicals using a Cytoscape Web display to enhance the visualization and interconnectivity of the molecules that form the share toxicogenomic profile (Figure 4b ). The Cytoscape map is customizable by the user, allowing for different layout styles and toggling node and edge labels. Right-clicking on any node provides additional options. The map may be exported in several image formats (PNG, PDF, SVG) and data formats (XGMML, GRAPHML, SIF). This visualization works particularly well with smaller networks and requires both JavaScript and Flash on a user's computer. For larger networks, a XGMML file is provided for users to use via a desktop version of the open-source application Cytoscape (26) . (iii) To curate disease information, CTD biocurators annotate using MEDIC (9), a merged disease vocabulary of Medical Subject Headings (MeSH) disease terms (27) and the Online Mendelian Inheritance in Man (28) . MEDIC contains over 9700 primary terms and 59 000 synonyms, making it a practical disease vocabulary that is both deep and broad (9) . To summarize this vocabulary, we MEDIC-Slim reduces the complexity of interpreting inferred disease relationships. Currently, CTD contains data for almost 6000 unique diseases, including >200 000 direct disease relationships and 11 million inferred relationships (Table 1) . Viewing this extensive data set via the 36 MEDIC-Slim categories provides a perspective of the entire disease landscape in CTD ( Figure 5 ). The top disease categories for both direct and inferred relationships currently include cancer, nervous system, cardiovascular and digestive system diseases. To help manage this knowledge, users can now filter disease relationships via MEDIC-Slim categories on any 'Diseases' data tab in CTD. For example, the chemical bisphenol A is associated with 1965 unique diseases. A user interested in exploring how that compound may affect heart defects can apply the 'cardiovascular disease' filter to retrieve just the 188 diseases relevant to that filter ( Figure 6 ). Figure 5 . CTD disease landscape. CTD currently contains over 11 million disease relationships (both direct and inferred) for 5987 unique diseases MEDIC-Slim reduces the complexity of this information into 36 generic disease categories (y-axis) to show the overall landscape of disease information at CTD for both direct relationships (blue bars) and inferred relationships (yellow bars), as a percentage of the total number of relationships.
Other CTD features
In addition to the above features, we also increased the utility of GO and pathway annotations at CTD. These annotations are directly assigned to gene symbols by external sources, and through integration with CTD data we can create novel connections to diseases with which the same genes are involved. We expanded CTD's GO and Pathway pages to include a 'Diseases' data tab that list these associations. For example, as of July 2012 CTD's Pathway page for 'TGF-beta signaling pathway' (http://ctdbase.org/ detail.go?type=pathway&acc=KEGG%3a04350) is directly associated with 375 genes via KEGG, which in turn can be integrated via CTD to 316 diseases, including lung neoplasms, craniofacial abnormalities and sepsis. Similar integrated relationships are available for GO terms on CTD's GO pages, allowing users to explore diseases from GO and pathway perspectives. On CTD Gene pages, the listed synonyms are now seamlessly hyperlinked to keyword query searches to help find related genes. For example, CTD's Gene page TP53 (http://ctdbase.org/detail.go?type=gene&acc=7157) contains the synonym 'p53 tumor suppressor', which, when clicked, finds other genes that use that phrase, including the mouse-specific version of the gene (called TRP53), as well as several p53-binding proteins (e.g. TP53BP1 and TP53BP2). This simple feature can alert users to other genes that may be relevant to their gene-of-interest and is particularly helpful because of CTD's cross-species gene aggregation.
Finally, the Batch Query tool (http://ctdbase.org/tools/ batchQuery.go) has been expanded to accommodate literature retrieval by now accepting PubMed identification numbers or digital object identifiers as an input type. This feature allows users to retrieve all curated data content for batches of articles.
SUMMARY AND FUTURE DIRECTIONS
CTD provides detailed information about manually curated chemical-gene interactions, chemical-disease Figure 6 . MEDIC-Slim adds functionality, reduces complexity of disease information and eases data management. CTD biocurators use the MEDIC disease vocabulary to curate disease relationships. These MEDIC diseases are now mapped to 36 MEDIC-Slim generic disease categories, which help reduce complexity and add the functionality of allowing users to easily retrieve and manage the information. Under its 'Diseases' data tab, the chemical bisphenol A is associated with 1965 diseases (red box). This data set can be filtered for any of the 36 MEDIC-Slim categories from a pick-list, such as 'Cardiovascular disease' (red circle), to retrieve only the 188 cardiovascular diseases associated with bisphenol A (red arrow).
relationships and gene-disease relationships. Integrating these core data with other data sets, CTD helps turn knowledge into discoveries by identifying novel connections between chemicals, genes, diseases, pathways and GO annotations that might not otherwise be apparent using other biological resources.
Here, we have highlighted recent major improvements to CTD, including expanded data content, greater connectivity with other databases, new analytical tools and novel visualization strategies that help users view and organize information. These features make CTD a unique scientific resource for promoting understanding of the effects of environmental chemicals on human health and for generating testable hypotheses about the mechanisms underlying the etiology of environmental diseases.
In the future, we hope to expand the depth and breadth of the manually curated core data, especially by curating recent toxicology journals triaged via a new journalcentric approach to help improve data currency at CTD (A. P. Davis et al., submitted for publication) and expanding into new knowledge spaces, including exposure science (29) and phenotypes. We also plan to increase the visualization and analysis capacity of CTD. For example, heat maps are practical visual devices that help users rapidly interpret large data sets (30) . We are currently experimenting with different visualization prototypes to present MEDIC-Slim summaries for disease relationships.
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